Cure My Disease

Don't miss your cure!

 Log in / Sign up

Study probes how teens with autism or schizophrenia read emotions and intentions

NCT ID NCT01805128

Knowledge-focused Sponsor: Centre Hospitalier Universitaire de Nice Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study looked at how teenagers with autism or schizophrenia understand emotions, metaphors, and social situations compared to healthy teens. Researchers tested 60 participants using facial emotion recognition and other tasks. The goal was to find out if social difficulties are unique to each condition or shared, which could improve future therapies.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this research could help identify specific social thinking challenges in autism and schizophrenia, guiding better therapies.
What could go wrong
This is an observational study, not a treatment trial. It may not lead to direct benefits for participants, and findings may not apply to all individuals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Start date

Jan 2013

Finished

May 2013

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 18 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Child with a DSM-IV diagnosis of schizophrenia or autism spectrum disorder: * Schizophrenic patients, positive to the award of psychosis section of the Kiddie SADS and having a negative ADI. or: * Patients with autism spectrum disorder, diagnosed by the scale ADI (Autism Diagnostic Interview) or ADOS (Autism Diagnostic Observation Schedule): Autism Asperger and PDD nos. These patients do not respond to a diagnosis of psychosis Kiddie-SADS according. * Total IQ greater than or equal to 70 Exclusion Criteria: * Genetic disorders, neurological and neurosensory * Child satisfy both the diagnosis of autism spectrum disorder and schizophrenia than (comorbidity). * Will not be included patients who participate in a study on rehabilitation for social skills.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Autism spectrum disorder are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autism autism spectrum disorder schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Autistic disorder Schizophrenia

Contacts and locations

Locations

  • CHU de Nice

    Nice, 06000, France

  • Centre Hospitalier d'Antibes Juans les Pins

    Antibes, 06600, France

  • Centre hospitalier de Cannes

    Cannes, 06400, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.